crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - zdravila za zdravljenje bolezni kosti - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
alpha d3 1 mikrogram mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 1 µg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 0,25 mikrograma mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 0,25 µg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 1 mikrogram mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 1 mg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 0,5 mikrograma mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 0,5 µg / 1 kapsula - alfakalcidol (kalcidiol)
rupurut 500 mg žvečljive tablete
bayer d.o.o. - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit
rupurut 500 mg žvečljive tablete
bayer d.o.o. - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit
talcid 500 mg žvečljive tablete
bayer d.o.o. - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit
rupurut forte 1000 mg žvečljive tablete
bayer d.o.o. - hidrotalcit - žvečljiva tableta - hidrotalcit 1000 mg / 1 tableta - hidrotalcit
rutacid 500 mg žvečljive tablete
krka, d.d., novo mesto - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit